Aptargroup Stock News

Shares of AptarGroup, Inc. (NYSE:ATR) hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $116.59 and last traded at $116.59, with a volume of 7018 shares trading hands. The stock had previously closed at $118.69. ATR has been the subject of a number of analyst reports. William []

Aptus Capital Advisors LLC increased its position in AptarGroup, Inc. (NYSE:ATR) by 21.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,130 shares of the industrial products companys stock after acquiring an additional 2,720 shares during the quarter. Aptus Capital Advisors LLCs holdings in []

Speece Thorson Capital Group Inc. decreased its position in shares of AptarGroup, Inc. (NYSE:ATR) by 0.5% in the third quarter, Holdings Channel reports. The fund owned 46,531 shares of the industrial products companys stock after selling 227 shares during the period. Speece Thorson Capital Group Inc.s holdings in AptarGroup were worth $5,553,000 as of its []

AptarGroup, Inc. (NYSE:ATR) Research analysts at Jefferies Financial Group lowered their Q1 2022 earnings estimates for AptarGroup in a report released on Monday, December 13th. Jefferies Financial Group analyst D. Rizzo now anticipates that the industrial products company will post earnings of $0.94 per share for the quarter, down from their previous forecast of []

Dearborn Partners LLC lifted its holdings in AptarGroup, Inc. (NYSE:ATR) by 0.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 255,425 shares of the industrial products company’s stock after acquiring an additional 1,361 shares during the period. Dearborn Partners LLC’s […]

Dearborn Partners LLC raised its stake in shares of AptarGroup, Inc. (NYSE:ATR) by 0.5% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 255,425 shares of the industrial products company’s stock after purchasing an additional 1,361 shares during the period. Dearborn Partners […]

AMCR vs. ATR: Which Stock Is the Better Value Option?

AMCR vs. ATR: Which Stock Is the Better Value Option?

Boston Trust Walden Corp cut its stake in AptarGroup, Inc. (NYSE:ATR) by 2.0% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 704,666 shares of the industrial products companys stock after selling 14,534 shares during the quarter. Boston Trust Walden Corps holdings in AptarGroup were worth $84,102,000 as of its most recent SEC filing. Other []

Garrison Asset Management LLC boosted its position in AptarGroup, Inc. (NYSE:ATR) by 1.6% during the third quarter, HoldingsChannel.com reports. The fund owned 25,552 shares of the industrial products companys stock after buying an additional 396 shares during the quarter. AptarGroup makes up 1.9% of Garrison Asset Management LLCs portfolio, making the stock its 24th biggest []

Stratos Wealth Partners LTD. raised its holdings in shares of AptarGroup, Inc. (NYSE:ATR) by 8.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,792 shares of the industrial products companys stock after acquiring an additional 1,042 shares during the quarter. Stratos Wealth Partners []

Fifth Third Bancorp trimmed its position in shares of AptarGroup, Inc. (NYSE:ATR) by 11.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,738 shares of the industrial products companys stock after selling 883 shares during the period. Fifth Third Bancorps holdings in AptarGroup were worth []

AptarGroup, Inc. (NYSE:ATR) has been assigned a consensus recommendation of Hold from the seven research firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have given a buy recommendation to the company. The average 1-year price target []

"Oral dosage formulations have evolved as an appropriate, and in some cases favored, alternative to traditional tablets and capsules over the past three decades. Oral Spray is a product intended for oral administration whereby inert or active ingredients are sprayed